Sustainability & Climate

Procter & Gamble unveils a massive athlete support plan for Milano Cortina 2026, blending personal care services with a powerful marketing strategy.

With tooth decay as the #1 childhood disease, Georgia dentists are launching a statewide blitz of free care and education to protect kids' smiles.

A C$20M investment validates Corus's unique doctor-led model, fueling a major expansion across the booming North American orthodontic market.

Devonian appoints veteran CFO Dennis Turpin and corrects stock options, signaling a strategic shift as it aims to overcome financial hurdles and advance its pipeline.

Identity governance leader Pathlock earns a spot in a key Gartner guide for its ability to tackle complex and costly SAP software license management.

A new collaboration adapts world-class cancer treatment standards for Vietnam, offering new hope for women battling breast and ovarian cancer.

Alcon launches PRECISION7, a new one-week contact lens, creating a category that blends advanced comfort with an intuitive, affordable replacement schedule.

Beyond retail, Pacsun is investing in the next generation of musicians, using co-creation and strategic partnerships to build authentic cultural relevance.

The iconic F1 team is integrating Anthropic's Claude AI to navigate 2026's massive rule changes, aiming to outthink rivals and return to the top.

Burberry and Coty launch Hero Elixir, a potent new fragrance exploring duality and competing in the high-stakes, ultra-premium men's scent market.

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

A new deal with Sourcewell lets Alliant streamline insurance for 50,000+ public agencies, cutting red tape and boosting risk management nationwide.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

A new AI embedded in smart meters detects grid faults in real time, promising to stop wildfires and power outages before they start. Here's how it works.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

Rain Bird's new software integrations with Spectrum and Watertronics promise to revolutionize golf course management with data-driven precision and sustainability.

By focusing on local stores instead of online ads, SurgePays' LinkUp Mobile has quietly gained 100,000 subscribers. Here's how they did it.

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

The Spanish biotech firm strengthens its IP for a novel aggression treatment, targeting a growing multi-billion dollar Japanese CNS market.